More on Hepatitis C
KEI Documents and commentary regarding Hepatitis C Virus (HCV) related issues
Hepatitis Timeline: http://goo.gl/83sp9J
Search Results for: drug patents
WHA67: Statement of South Africa on behalf of the African Region on Access to Essential Medicines
On Friday, 23 May 2014, the World Health Assembly is currently discussing access to essential medicines in the context of resolution EB134.R16, tabled China in January 2014. The following statement was delivered by South Africa on behalf of the 47 members of the African region. South Africa highlighted the point that “vaccines and anti-cancer drugs remain out of reach of millions of people in both developed and developing countries.”
KEI Comments regarding USTR Public Interest Trade Advisory Committee
Comments of KEI, regarding USTR Request For Comments From The Public On The Creation Of The Public Interest Trade Advisory Committee And Request For Nominees To That Committee.
Submitted to Regulations.gov on March 25, 2014, under docket number USTR-2014-0005.
Intellectual property issues are an important element of US trade agreements, and according to a recent study by Open Secrets, the most intensively lobbied issue, by far.
Resurrecting the Ghost of Høsbjør Past: Global Fund seeks to establish global framework on tiered pricing enforced by WTO rules
Informed sources have revealed that Mark Dybul, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, is the brains behind an initiative to create global framework for the tiered pricing or in the Global Fund’s own words, “Equitable Access to Essential Medicines and Vaccines: Developing a Framework for Success”, enforced by the rules of the World Trade Organization. KEI has obtained this internal concept note prepared by the Global Fund which we understand is a work in progress.
KEI’s comments on Special 301, March 7, 2014
KEI’s Additional Comments Special 301
March 7, 2014
James Love, Knowledge Ecology International
Docket # USTR-2013-0040
These comments supplement KEI’s February 7, 2014 written submission (Also available here: https://www.keionline.org/ustr/special301, and /node/1927), and our February 24, 2014 oral testimony, and provide also comment or reply to the written or oral submissions by others.
1. India is an important source of affordable medicines.
EU proposals for TTIP, TRADE IN SERVICES, INVESTMENT AND E-COMMERCE, July 2, 2013
ZEIT ONLINE has published the EU’s July 2, 2013 proposals for TRADE IN SERVICES, INVESTMENT AND E-COMMERCE in the TTIP negotiation. A copy of the proposal is available here. Tags: ISDS, TTIP
TRADE IN SERVICES, INVESTMENT AND E-COMMERCE
Chapter I General provisions
Chapter II Investment
Chapter III Cross border supply of services
Continue Reading
WTO TRIPS Council (February 2014) – India’s intervention on IP and Innovation: University Technology Partnerships
On Tuesday, 25 February 2014, India delivered the following intervention at the WTO TRIPS Council on agenda item 12 (IP and Innovation: University Technology Partnerships). The United States of America tabled this standalone agenda item on University Technology Partnerships in the context of IP and Innovation.
Agenda 12 : IP and Innovation: University Technology Partnerships
2014, BIO discussion of Brazil
The Biotechnology Industry Organization (BIO) submission (7 February 2014, USTR-2013-0040) to USTR’s 2014 Special 301 Review requested USTR to place Brazil on the Priority Watch List.
Brazil
Alliance for Fair Trade with India (AFTI): Ground zero for trade sanctions against India
The Alliance for Fair Trade with India (AFTI) was created in June 2013, to lobby for “increased action to address the erosion of intellectual property rights (“IPR”) in India.” According to the group, it is “comprised of organizations representing a range of U.S. industries adversely impacted by India’s troubling and frequently discriminatory policies, including manufacturing, agriculture, telecommunications, pharmaceuticals and beyond.”
2014, U.S. Chamber of Commerce (Global Intellectual Property Center) discussion of India
The U.S. Chamber of Commerce’s (Global Intellectual Property Center) submission (7 February 2014, USTR-2013-0040) to USTR’s 2014 Special 301 Review requests USTR classify India as a Priority Foreign Country specifically citing concerns over compulsory licensing. The submission noted that India… Continue Reading